Biogen, Inc. v. Iancu
19-1253 | U.S. Court of Appeals, Federal Circuit
Interested in this case?
Request a Demo Track this case, and find millions of cases like it, let us show you how.Filing Date | # | Docket Text |
---|---|---|
3/26/2019 | 26 | ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [25] filed by Appellant Biogen, Inc. The proceeding is DISMISSED. Each side shall bear its own costs. ISSUED AS A MANDATE: 03/26/2019. Service as of this date by the Clerk of Court. [595508] [JAL] [Entered: 03/26/2019 01:04 PM] |
3/26/2019 | 25 | MOTION of Appellant Biogen, Inc. to voluntarily dismiss appeal pursuant to FRAP 42(b). [Consent: unopposed]. Service: 03/26/2019 by email. [595450] [19-1253] [Nicholas Groombridge] [Entered: 03/26/2019 10:48 AM] |
3/1/2019 | 24 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: motion to extend time to file brief Docket No. [22], ERROR: Appellant's motion [22] did not contain a certificate of compliance with the word count. CORRECTION: For future motions, pursuant to FRAP 32(g)(1), please include a certificate of compliance with the word count. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [589528] [JAL] [Entered: 03/01/2019 08:27 AM] |
3/1/2019 | 23 | **TEXT ONLY** ORDER granting motion to extend time to file brief [22] filed by Appellant Biogen, Inc. Appellant's opening brief is due 04/10/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [589527] [JAL] [Entered: 03/01/2019 08:25 AM] |
2/28/2019 | 22 | MOTION of Appellant Biogen, Inc. to extend the time to 04/10/2019 to file the Appellant's brief. [Consent: unopposed]. Service: 02/28/2019 by email. [589504] [19-1253] [Nicholas Groombridge] [Entered: 02/28/2019 05:16 PM] |
2/26/2019 | 21 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [588587] [JAL] [Entered: 02/26/2019 09:50 AM] |
2/8/2019 | 20 | Docketing Statement for the Intervenor Iancu. Service: 02/08/2019 by email. [584352] [19-1253] [Sarah Craven] [Entered: 02/08/2019 09:38 AM] |
1/17/2019 | 19 | Notice from United States Patent and Trademark Office: Thomas Krause Appointed USPTO Deputy General Counsel and Solicitor. Service: 01/17/2019 by clerk. [579026] [17-2122, 18-1959, 18-2259, 19-1011, 19-1073, 19-1074, 19-1162, 19-1177, 19-1178, 19-1193, 19-1214, 19-1252, 19-1253] [JAL] [Entered: 01/17/2019 03:06 PM] |
1/16/2019 | 18 | Certified list from the United States Patent and Trademark Office. Service: 01/15/2019 by email. Appellant's brief is due 03/18/2019. [578448] [JAL] [Entered: 01/16/2019 10:26 AM] |
1/9/2019 | 17 | ORDER filed. The Director of the United States Patent and Trademark office is added as an intervenor. The revised official caption is reflected in the order. The Director shall file a docketing statement no more than 30 days from the issuance of this order. Service as of this date by the Clerk of Court. [576806] [JAL] [Entered: 01/09/2019 09:45 AM] |
1/7/2019 | 16 | Entry of appearance for Farheena Y. Rasheed as of counsel for Director - United States Patent and Trademark Office. Service: 01/07/2019 by email. [576453] [19-1253] [Farheena Rasheed] [Entered: 01/07/2019 04:03 PM] |
1/7/2019 | 15 | Entry of appearance for Thomas W. Krause as of counsel for Director - United States Patent and Trademark Office. Service: 01/07/2019 by email. [576414] [19-1253] [Thomas Krause] [Entered: 01/07/2019 03:31 PM] |
1/7/2019 | 14 | Entry of appearance for Joseph Matal as of counsel for Director - United States Patent and Trademark Office. Service: 01/07/2019 by email. [576410] [19-1253] [Joseph Matal] [Entered: 01/07/2019 03:28 PM] |
1/7/2019 | 13 | Entry of appearance for Sarah E. Craven as principal counsel for Director - United States Patent and Trademark Office. Service: 01/07/2019 by email. [576403] [19-1253] [Sarah Craven] [Entered: 01/07/2019 03:23 PM] |
1/7/2019 | 12 | Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 01/07/2019 by email. [576400] [19-1253] [Sarah Craven] [Entered: 01/07/2019 03:17 PM] |
12/18/2018 | 11 | Docketing Statement for the Appellant Biogen, Inc.. Service: 12/18/2018 by email. [572855] [19-1253] [Nicholas Groombridge] [Entered: 12/18/2018 05:56 PM] |
12/18/2018 | 10 | Certificate of Interest for the Appellant Biogen, Inc.. Service: 12/18/2018 by email. [572851] [19-1253] [Nicholas Groombridge] [Entered: 12/18/2018 05:55 PM] |
12/18/2018 | 9 | Entry of appearance for Megan F. Raymond as of counsel for Appellant Biogen, Inc.. Service: 12/18/2018 by email. [572849] [19-1253] [Nicholas Groombridge] [Entered: 12/18/2018 05:51 PM] |
12/18/2018 | 8 | Entry of appearance for J. Steven Baughman as of counsel for Appellant Biogen, Inc.. Service: 12/18/2018 by email. [572847] [19-1253] [Nicholas Groombridge] [Entered: 12/18/2018 05:49 PM] |
12/18/2018 | 7 | Entry of appearance for Nicholas Groombridge as principal counsel for Appellant Biogen, Inc.. Service: 12/18/2018 by email. [572844] [19-1253] [Nicholas Groombridge] [Entered: 12/18/2018 05:45 PM] |
12/17/2018 | 6 | ORDER filed. The official caption and short caption are revised in light of Celltrionâs non-participation, as reflected in this order. Within 30 days of the date of filing of this order, the Director of the United States Patent and Trademark Office is directed to inform the court whether he intends to intervene in this appeal. Service: 12/17/2018 by clerk. [572217] [NL] [Entered: 12/17/2018 02:04 PM] |
12/12/2018 | 5 | Notice from Appellee Celltrion, Inc.: Notice of Non-Participation. Service: 12/11/2018 by email. [571090] [JAL] [Entered: 12/12/2018 08:54 AM] |
12/7/2018 | 4 | ORDER filed. Notice of the appellant's constitutional challenge [3] is hereby certified to the Attorney General. No later than 30 days from the date of filing of this order, the Attorney General is directed to inform this court whether the United States intends to intervene in this appeal. Service: 12/07/2018 by. [570233] [LMS] [Entered: 12/07/2018 01:47 PM] |
12/6/2018 | 3 | Notice from Appellant Biogen, Inc. Pursuant to Fed. R. App. P. 44. Service: 12/06/2018 by email. [570062] [19-1253] [Jon Baughman] [Entered: 12/06/2018 08:22 PM] |
12/6/2018 | 2 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: case opening document Docket No. [1], ERROR: Upon review of Appellant's Notice of Appeal [1] for compliance with the Rules, it appears the appeal may raise an argument falling under Fed. R. App. P. 44. CORRECTION: Counsel is reminded to submit the required notice if Fed. R. App. P. 44 applies. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [569988] [JAL] [Entered: 12/06/2018 03:55 PM] |
12/4/2018 | 1 | Appeal docketed. Received: 12/04/2018. [569663] Entry of Appearance due 12/18/2018. Certificate of Interest is due on 12/18/2018. Docketing Statement due 12/18/2018. Certified List due on 01/14/2019. [JAL] [Entered: 12/04/2018 04:32 PM] |